Tag Archives: Andre Audet

Appointments Constance Therapeutics Bernard Fortier

Tetra Bio-Pharma Accelerates Growth Strategy with Appointment of Bernard Fortier as CEO

Tetra Bio-Pharma Accelerates Growth Strategy with Appointment of Bernard Fortier as CEO

OTTAWA, Ontario July 24, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF) today announced that it has strengthened its management team with the appointment of Bernard Fortier to the position of Chief Executive Officer, effective today, July 24, 2017.

Aphria

Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma via Private Placement to Fund PhytoPain Pharma Clinical Trials

OTTAWA, Ontario, Dec. 6, 2016 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra Bio” or “the Company”) (OTC PINK:GRPOF) is conducting a non-brokered private placement with Aphria Inc. (OTCQB:APHQF).

GrowProws

GrowPros Announces the Acquisition of Laboratoires Holizen Inc. and a $600,000 Non-Brokered Private Placement

OTTAWA, Ontario, June 22, 2016 /Weed Wire/ — GrowPros Cannabis Ventures Inc. (“GrowPros” or the “Company”) (CSE:GCI) is pleased to announce the acquisition of the assets of Laboratoires Holizen Inc. (“Holizen”) for $450,000.


Top